Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03515317 |
Other study ID # |
N201704027 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 22, 2018 |
Est. completion date |
May 11, 2022 |
Study information
Verified date |
April 2024 |
Source |
Taipei Medical University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Background: Cognitive impairment is common in patients with traumatic brain injury (TBI) at
all levels of severity. Such impairments may affect their ability to return to work and thus
increase healthcare costs and the associated economic burdens. Both cognitive rehabilitation
and stimulant medications are widely used to manage post-traumatic cognitive impairments;
however, previous metaanalyses failed to demonstrate their beneficial effects on cognitive
recovery in patients with TBI. Nurses, the first-line healthcare providers, should therefore
seek and use an alternative approach for dealing with post-traumatic cognitive deficits.
Purpose: To assess the effects of low resolution tomography (LoRETA) Z -score neurofeedback
(NF) and theta/beta NF in alleviating cognitive impairments in patients with TBI as well as
the possible mechanism through which they provide this alleviation. We hypothesize that
adults with TBI receiving LoRETA Z-score NF and theta/beta NF will experience the
improvements in cognitive functions while participants in the control group will not.
Description:
Cognitive impairment is the most common and debilitating residual symptom of traumatic brain
injury (TBI) at all levels of severity and the prevalence of cognitive impairments varies,
depending on the severity of the head injury and the time since the injury. Such impairments
substantially affect a person's ability to return to productive activity and health-related
quality of life. Furthermore, disabilities related to cognitive impairments following TBI
increase healthcare costs and economic burden. Memory, attention, and information processing
speed are basic cognitive functions. Deficits in such functions subsequently exacerbate
disturbances in more complex cognitive functions (e.g., executive function). Therefore,
targeting basic cognitive functions is the first priority of clinical treatments for
post-traumatic cognitive impairments.
Cognitive rehabilitation, a nonpharmacological intervention, is the first-line treatment for
the management of cognitive impairments following TBI. However, the findings of previous
reviews are still debated, with one metaanalysis supporting its beneficial effects on
attention recovery and two metaanalyses denying the positive association between cognitive
rehabilitation and cognitive recovery. Pharmacotherapies (e.g., methylphenidate) has been
potentially used to accelerate cognitive recovery in patients with TBI. Nevertheless, recent
systematic reviews failed to prove its effects on cognitive recovery. Moreover, adverse
effects may contribute to the discontinuation of stimulant medication use.Taken together,
current treatments are insufficient for managing post-traumatic cognitive impairments.
Nurses, the first-line healthcare providers, should therefore seek and employ an alternative
approach to deal with cognitive impairments following TBI.
Both abnormal network connectivity of the brain (e.g., low neural communication between
different brain areas) and dysregulated electroencephalographs (EEGs, e.g., increases in
alpha and theta, and decrease in beta) following brain damage have been strongly connected to
deficits in memory, sustained attention, and information processing speed. Neurofeedback (NF)
can target and alter dysregulated brain functioning by giving real-time feedback of EEG
activity to patients. Existing literatures have shown that NF might improve attention
performance after TBI. Nonetheless, the effects of NF on other cognitive functions, such as
memory and speed of information processing, have not been ascertained. In addition, limited
methodological features of previous studies, including single group, pre- and posttreatment
study design, small number of participants, and inconsistent treatment protocols, restrict
their generalizability and practicability. Most importantly, knowledge regarding cognitive
improvements being concomitant with changes in EEGs and the long-term effects of NF on
cognitive recovery following TBI is still lacking.